Comparison of the efficacy and safety of tolterodine 2 mg and 4 mg combined with an α-blocker in men with lower urinary tract symptoms (LUTS) and overactive bladder: a randomized controlled trial.
about
Additional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy.Nocturia: aetiology and treatment in adults.Treatment of Concomitant OAB and BPH.A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms.
P2860
Comparison of the efficacy and safety of tolterodine 2 mg and 4 mg combined with an α-blocker in men with lower urinary tract symptoms (LUTS) and overactive bladder: a randomized controlled trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Comparison of the efficacy and ...... a randomized controlled trial.
@en
Comparison of the efficacy and ...... h lower urinary tract symptoms
@nl
type
label
Comparison of the efficacy and ...... a randomized controlled trial.
@en
Comparison of the efficacy and ...... h lower urinary tract symptoms
@nl
prefLabel
Comparison of the efficacy and ...... a randomized controlled trial.
@en
Comparison of the efficacy and ...... h lower urinary tract symptoms
@nl
P2093
P2860
P356
P1433
P1476
Comparison of the efficacy and ...... a randomized controlled trial
@en
P2093
Hyun Hwan Sung
Kyu-Sung Lee
Soonhyun Yook
Tae Heon Kim
Yoon Seok Suh
P2860
P304
P356
10.1111/BJU.13267
P50
P577
2015-09-23T00:00:00Z